Jeff Evans has been editor of Rheumatology News/MDedge Rheumatology and the EULAR Congress News since 2013. He started at Frontline Medical Communications in 2001 and was a reporter for 8 years before serving as editor of Clinical Neurology News and World Neurology, and briefly as editor of GI & Hepatology News. He graduated cum laude from Cornell University (New York) with a BA in biological sciences, concentrating in neurobiology and behavior.
News
Fludarabine added to interferon hints at benefits for breakthrough MS
News
MRI findings beyond sacroiliitis not necessary for classifying nonradiographic axial SpA
News
Glatiramer acetate didn’t affect birth outcomes in women with multiple sclerosis
News
Secukinumab receives FDA approval for psoriatic arthritis, ankylosing spondylitis
News
FDA rejects antisense oligonucleotide drug for Duchenne muscular dystrophy
News
Study bolsters argument for sodium channel role in MS cerebellar dysfunction
News
Anti-SPAG16 antibodies could be prognostic marker in primary progressive MS
News
T-cell biomarker not viable for detecting PML risk with natalizumab
News
Rheumatology trends, research, concerns highlighted for 2016
News
Evidence points to early brain cell death as catalyst for MS inflammation, demyelination
News
Lateral wedge insoles provide minimal biomechanical help in knee OA
News
BRCA1 may have an impact in Alzheimer’s disease
News
State laws, regulatory concerns complicate biosimilars landscape
News
Pseudoatrophy with interferon beta-1a may warrant MRI delay in MS patients
Video
